Andrew MacIsaac

Andrew MacIsaac

executive Canada

Andrew MacIsaac is the CEO of Applied Pharmaceutical Innovation (API), a non-profit laboratory and manufacturing facility in Edmonton. He is involved in the development of Vimy Pharmaceuticals' generic semaglutide, emphasizing the importance of domestic drug production in Canada.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned

No country-level mention data available.

Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Canada Canada: Andrew MacIsaac is the CEO of Applied Pharmaceutical Innovation, excited to work on the semaglutide drug. 8

Dave Suchon Farris Smith Frederick Banting Charles Best John Macleod James Collip Dan Drucker
The Globe and Mail: Canadian firm enters race to bring generic Ozempic to market